0001209191-20-009035.txt : 20200212
0001209191-20-009035.hdr.sgml : 20200212
20200212201043
ACCESSION NUMBER: 0001209191-20-009035
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200210
FILED AS OF DATE: 20200212
DATE AS OF CHANGE: 20200212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Russell Edward Keith
CENTRAL INDEX KEY: 0001655234
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 20606555
MAIL ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-10
0
0000353569
QUIDEL CORP /DE/
QDEL
0001655234
Russell Edward Keith
9975 SUMMERS RIDGE ROAD
SAN DIEGO
CA
92121
0
1
0
0
SVP, Business Development
Common Stock
2020-02-10
4
A
0
1201
0.00
A
17679
D
Common Stock
2020-02-10
4
F
0
489
77.52
D
17190
D
Reflects release of restricted stock units that were previously reported on a Form 4.
Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
Robert J. Bujarski, attorney-in-fact for Edward K. Russell
2020-02-12